StemCell Inc.

Top Story

MedCity morning read, Wednesday, Feb. 18

The stocks of stem cell therapy developers got a big boost on Tuesday, despite a huge loss for the overall stock market. Investors are expecting Pres. Barrack Obama to issue an executive order lifting a federal ban on funding research that uses embryonic stem cells.